The National Institutes of Health’s Clinical and Translational Science Awards (CTSA) program aims to accelerate translational research by providing support to investigators in order to bring new knowledge from the bench to the bedside via changes in public awareness, practice guidelines, health policy, and legislation. Nevertheless, it can be difficult to measure the impact of such support on translational outcomes, such as in public policy changes.
In a new study published in Academic Medicine, lead author Nicole Llewellyn, Ph.D., Emory University School of Medicine, Associate Director, Georgia CTSA Evaluation and Continuous Improvement, evaluated how CTSA-supported research has extended its impact beyond academia to influence public policy. Using cutting-edge bibliometric tools, Georgia CTSA partnered with CTSA evaluation leaders at Case Western Reserve University and Virginia Commonwealth University to demonstrate how CTSA-supported research has been used in public health and policy literature…
Read the full article here.
